« Back to Record
Citation APA

Bottomley, A., Coens, C., Suciu, S., Santinami, M., Kruit, W., Testori, A., Marsden, J., Punt, C., Sales, F., Gore, M., Mackie, R., Kusic, Z., Dummer, R., Patel, P., Schadendorf, D., Spatz, A., Keilholz, U., & Eggermont, A. (2009). Adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma: a phase III randomized controlled trial of health-related quality of life and symptoms by the European Organisation for Research and Treatment of Cancer Melanoma Group. Journal of clinical oncology, 27(18), 2916-2923. doi:10.1200/JCO.2008.20.2069


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/119835

Bottomley, A., Coens, C., Suciu, S., Santinami, M., Kruit, W., Testori, A., Marsden, J., Punt, C., Sales, F., Gore, M., Mackie, R., Kusic, Z., Dummer, R., Patel, P., Schadendorf, D., Spatz, A., Keilholz, U., & Eggermont, A. (2009). Adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma: a phase III randomized controlled trial of health-related quality of life and symptoms by the European Organisation for Research and Treatment of Cancer Melanoma Group. Journal of clinical oncology, 27(18), 2916-2923. doi:10.1200/JCO.2008.20.2069